Hosted on MSN1mon
Vanda Pharmaceuticals targets $1B revenue by 2030 with expanded psychiatry portfolioAdditionally, the European Medicines Agency is reviewing a marketing ... attributed to higher SG&A expenses related to commercial launches. Vanda projects 2025 revenues between $210 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback